Prestige Consumer Healthcare Inc. PBH
44.33 USD -8.95 (-16.80%)
At closeNov 5, 2026, 4:00 PM EST
44.32 -0.01 -0.02%
After hours · Nov 5, 4:00 PM ET
43.79 Day range 50.22
42.62 52-week range 71.07
- YTD
- -28.14%
- 1 year
- -25.91%
News
zacks.com Compared to Estimates, Prestige Consumer Healthcare (PBH) Q2 Earnings: A Look at Key Metrics Although the revenue and EPS for Prestige Consumer Healthcare (PBH) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics…
benzinga.com Prestige Consumer Q2 2027 Earnings Call Transcript Prestige Consumer (NYSE:PBH) reported second-quarter financial results on Thursday. The transcript from the company’s second-quarter earnings call has been provided below.Benzinga APIs provide…
benzinga.com Prestige Consumer Lowers FY2027 Adj EPS Guidance from $4.55-$4.65 to $4.48-$4.55 vs $4.58 Est; Lowers FY2027 Sales Guidance from $1.290B-$1.315B to $1.280B-$1.290B vs $1.298B Est Prestige Consumer (NYSE:PBH) lowers FY2027 Adj EPS guidance from $4.55-$4.65 to $4.48-$4.55 vs $4.58 analyst estimate. Lowers FY2027 sales outlook from $1.290 billion-$1.315 billion to $1.280…
globenewswire.com Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results TARRYTOWN, N.Y., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first half fiscal 2027 ended September 30,…
businesswire.com Amylyx Pharmaceuticals to Host Investor Event at ObesityWeek® 2026 Featuring Leading PBH Experts CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Host Investor Event at ObesityWeek® 2026 Featuring Leading PBH Experts.
seekingalpha.com Riverwater Small Cap Strategy Q3 2026 Portfolio Update During the third quarter of 2026, the Small Cap strategy slightly underperformed its benchmark, the Russell 2000 Index, in a period in which small cap stocks broadly declined. Top contributors…
gurufocus.com Prestige Consumer Healthcare Inc (PBH) Shares Fall 3.4% -- What GF Score of 70 Tells Investors On October 23, 2026, Prestige Consumer Healthcare Inc (PBH) shares fell 3.4%, closing at $47.80. The stock has experienced significant volatility, with a 52-wee
zacks.com Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? PBH's brand-building, acquisitions and e-commerce growth support fiscal 2027 revenue gains, but competition and currency risks remain key challenges.
globenewswire.com Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results TARRYTOWN, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2027 second quarter and first half earnings release on…
benzinga.com Transcript: Prestige Consumer Q1 2027 Earnings Conference Call Prestige Consumer (NYSE:PBH) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to…
marketbeat.com Amylyx's Avexitide Phase III Win Sets Up FDA Filing for PBH Treatment Amylyx Pharmaceuticals NASDAQ: AMLX said its Phase III trial of avexitide in post-bariatric hypoglycemia, or PBH, met its primary endpoint and all secondary endpoints, positioning the company to…
zacks.com Best Value Stocks to Buy for October 1st BP and PBH made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 1, 2026.
zacks.com PBH vs. NEOG: Which Stock Is the Better Value Option? Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two companies is the best option for those looking…
prnewswire.com More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds While 63% say women are more comfortable discussing intimate wellness than five years ago, new research reveals a gap between cultural progress and personal comfort TARRYTOWN, N.Y., Sept. 30, 2026…
defenseworld.net Premium Brands (TSE:PBH) Reaches New 52-Week Low – Here’s What Happened Premium Brands Holdings Co. (TSE: PBH - Get Free Report) hit a new 52-week low during trading on Wednesday. The company traded as low as C$75.25 and last traded at C$75.55, with a volume of 13629…
zacks.com PBH or NEOG: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two stocks is more attractive to value…
seekingalpha.com Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
globenewswire.com Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference TARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will…
prnewswire.com Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test National survey commissioned by DenTek, the #1 OTC dental guard brand for nighttime teeth grinding, finds nearly 8 in 10 football fans keep thinking about the game after it ends, with many reporting…
zacks.com PBH vs. SYK: Which Stock Is the Better Value Option? Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for…
foxbusiness.com Nearly 40,000 eye drops recalled nationwide over possible contamination Prestige Brand Holdings is recalling 39,060 bottles of certain Clear Eyes drops over sterility concerns, according to a Food and Drug Administration report.
seekingalpha.com Amylyx: Upgraded To Strong Buy On LUCIDITY Outcome, Avexitide, And 2026 Catalysts Amylyx Pharmaceuticals, Inc. is upgraded to Strong Buy after positive phase 3 LUCIDITY results for avexitide in post-bariatric hypoglycemia [PBH]. Avexitide met its primary endpoint, achieving a 55%…
zacks.com PBH or SYK: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the…
benzinga.com Prestige Consumer Raises FY2027 Adj EPS Guidance from $4.42-$4.51 to $4.55-$4.65 vs $4.53 Est; Raises FY2027 Sales Guidance from $1.100B-$1.121B to $1.290B-$1.315B vs $1.179B Est Prestige Consumer (NYSE:PBH) raises FY2027 Adj EPS guidance from $4.42-$4.51 to $4.55-$4.65 vs $4.53 analyst estimate. Raises FY2027 sales outlook from $1.100 billion-$1.121 billion to $1.290…- benzinga.com Prestige Consumer Q1 Adj. EPS $0.98 Beats $0.88 Estimate, Sales $265.700M Beat $249.681M Estimate Prestige Consumer (NYSE:PBH) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.88 by 11.36 percent. This is a 3.16 percent increase over earnings of $0.95…
benzinga.com Canaccord Genuity Maintains Buy on Prestige Consumer, Lowers Price Target to $72 Canaccord Genuity analyst Susan Anderson maintains Prestige Consumer (NYSE:PBH) with a Buy and lowers the price target from $86 to $72.
benzinga.com Transcript: Prestige Consumer Q4 2026 Earnings Conference Call 
benzinga.com Prestige Consumer Sees FY2027 Adj EPS $4.42-$4.51 vs $4.79 Est; Sees Sales $1.100B-$1.121B vs $1.159B Est Prestige Consumer (NYSE:PBH) is looking for FY2027 Adj EPS of $4.42-$4.51 vs $4.79 analyst estimate. sees sales of $1.100 billion-$1.121 billion vs $1.159 billion analyst estimate.
benzinga.com Prestige Consumer Q4 Adj. EPS $1.23 Misses $1.39 Estimate, Sales $281.617M Miss $293.661M Estimate Prestige Consumer (NYSE:PBH) reported quarterly earnings of $1.23 per share which missed the analyst consensus estimate of $1.39 by 11.51 percent. This is a 6.82 percent decrease over earnings of…
benzinga.com Earnings Scheduled For May 13, 2026 - benzinga.com Oppenheimer Maintains Outperform on Prestige Consumer, Lowers Price Target to $65 Oppenheimer analyst Rupesh Parikh maintains Prestige Consumer (NYSE:PBH) with a Outperform and lowers the price target from $77 to $65.
benzinga.com Prestige Bets $1 Billion On World's Most Iconic Nasal Strip Prestige Consumer Healthcare acquires Breathe Right brand for $1.045 billion. Deal expands OTC portfolio into sleep & breathing categories.- benzinga.com Earnings Scheduled For March 19, 2026
- benzinga.com Earnings Scheduled For February 5, 2026
- benzinga.com Prestige Consumer Narrows FY2026 Adj EPS Guidance from $4.54-$4.58 to $4.54 vs $4.55 Est; Narrows FY2026 Sales Guidance from $1.100B-$1.115B to $1.100B vs $1.107B Est Prestige Consumer (NYSE:PBH) narrows FY2026 Adj EPS guidance from $4.54-$4.58 to $4.54 vs $4.55 analyst estimate. Narrows FY2026 sales outlook from $1.100 billion-$1.115 billion to $1.100 billion vs…
benzinga.com Insights into Prestige Consumer Q3 Earnings 
benzinga.com Prestige Consumer Q3 Adj. EPS $1.14, Inline, Sales $283.444M Beat $282.012M Estimate Prestige Consumer (NYSE:PBH) reported quarterly earnings of $1.14 per share which met the analyst consensus estimate. This is a 6.56 percent decrease over earnings of $1.22 per share from the same…
benzinga.com Prestige Consumer's Earnings: A Preview 
benzinga.com Earnings Scheduled For November 10, 2025 - benzinga.com Canaccord Genuity Maintains Buy on Prestige Consumer, Lowers Price Target to $88 Canaccord Genuity analyst Susan Anderson maintains Prestige Consumer (NYSE:PBH) with a Buy and lowers the price target from $100 to $88.
- benzinga.com Earnings Scheduled For November 6, 2025
- benzinga.com Prestige Consumer Raises FY2026 Adj EPS Guidance from $4.50-$4.58 to $4.54-$4.58 vs $4.51 Est; Affirms FY2026 Sales Guidance of $1.100B-$1.115B vs $1.104B Est Updated Fiscal 2026 Outlook"Looking ahead, for the full year, we remain committed to rebuilding long-term supply chain capacity in Clear Eyes and expect to close the Pillar5 transaction as planned.…
benzinga.com Jefferies Maintains Hold on Prestige Consumer, Lowers Price Target to $71 Jefferies analyst Keith Devas maintains Prestige Consumer (NYSE:PBH) with a Hold and lowers the price target from $75 to $71.
benzinga.com Why Prestige Consumer Healthcare's Outlook Looks Unhealthy Adhishthana.com Analysis: Prestige Consumer Healthcare's chart shows a bearish setup after a Cakra breakdown. Here's why weakness may persist.
benzinga.com Oppenheimer Maintains Outperform on Prestige Consumer, Lowers Price Target to $72 Oppenheimer analyst Rupesh Parikh maintains Prestige Consumer (NYSE:PBH) with a Outperform and lowers the price target from $82 to $72.
benzinga.com Canaccord Genuity Maintains Buy on Prestige Consumer, Lowers Price Target to $100 Canaccord Genuity analyst Susan Anderson maintains Prestige Consumer (NYSE:PBH) with a Buy and lowers the price target from $105 to $100.- benzinga.com Looking Into Prestige Consumer's Recent Short Interest
- benzinga.com Prestige Consumer Lowers FY2026 GAAP EPS Guidance from $4.70-$4.82 to $4.50-$4.58 vs $4.76 Est; Lowers FY2026 Sales Guidance from $1.140B-$1.155B to $1.100B-$1.115B vs $1.149B Est Prestige Consumer (NYSE:PBH) lowers FY2026 GAAP EPS guidance from $4.70-$4.82 to $4.50-$4.58 vs $4.76 analyst estimate. Lowers FY2026 sales outlook from $1.140 billion-$1.155 billion to $1.100…
- benzinga.com Prestige Consumer Q1 Adj. EPS $0.95 Misses $1.00 Estimate, Sales $249.530M Miss $261.000M Estimate Prestige Consumer (NYSE:PBH) reported quarterly earnings of $0.95 per share which missed the analyst consensus estimate of $1.00 by 5 percent. This is a 5.56 percent increase over earnings of $0.90…
- benzinga.com Earnings Scheduled For August 7, 2025